Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>G Sachs Keeps Buy on WUXI APPTEC, Lifts TP to HKD149.7
Recommend 0 Positive 0 Negative 1 |
||||
|
||||
|
WUXI APPTEC (02359.HK) reiterated its revenue growth guidance for this year at a prudent level during its earnings call, factoring in the assumption of USD depreciation, as well as the tailwinds from solid order backlog, continuous expansion of TIDES capacity, and accelerated growth in the small molecule D&M business, according to a report from Goldman Sachs. Management emphasized that the oral small molecule GLP-1 project will become an increasingly important growth driver starting this year. An increase in late-stage and commercialization project reserves will also enhance mid-term growth visibility. Goldman Sachs has raised its target price for WUXI APPTEC from HKD144.6 to HKD149.7 and kept the Buy rating unchanged. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
